Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

INTRODUCTION: Gout affects 2.5% of the UK's adult population and is now the most common type of inflammatory arthritis. The long-term management of gout requires reduction of serum urate levels and this is most often achieved with use of xanthine oxidase inhibitors, such as allopurinol. Febuxos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: MacDonald, Thomas M, Ford, Ian, Nuki, George, Mackenzie, Isla S, De Caterina, Raffaele, Findlay, Evelyn, Hallas, Jesper, Hawkey, Christopher J, Ralston, Stuart, Walters, Matthew, Webster, John, McMurray, John, Perez Ruiz, Fernando, Jennings, Claudine G
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2014
Matèries:
Research Methods
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120410/
https://ncbi.nlm.nih.gov/pubmed/25011991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005354
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars